YASMIN

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Ecuador, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug YASMIN contains a combination of these active pharmaceutical ingredients (APIs):

1 Drospirenone UNII N295J34A25 - DROSPIRENONE

Drospirenone is a progestogen. In a therapeutic dosage, drospirenone also possesses antiandrogenic and mild antimineralocorticoid properties. It has no estrogenic, glucocorticoid and antiglucocorticoid activity. This gives drospirenone a pharmacological profile closely resembling the natural hormone progesterone. Read about Drospirenone

2 17 alpha-Ethinylestradiol UNII 423D2T571U - ETHINYL ESTRADIOL

Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy. Read about 17 alpha-Ethinylestradiol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
YASMIN Film-coated tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03AA12	Drospirenone and ethinylestradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AA Progestogens and estrogens, fixed combinations
Discover more medicines within G03AA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 538912050015713, 538912070018003, 538913050022403, 538915060023503
Country: CA	Health Products and Food Branch	Identifier(s): 02261723, 02261731
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.893-11-07
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 00-2881, 2000-02881IP, 23022-17-4-2008, 3303827505, 63575, 63576, 8069-1-2-11, PL00010-0571, RVG23827
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 002391, 003911, 004000
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139812, 26464, 378893
Country: HK	Department of Health Drug Office	Identifier(s): 48905
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-993460030
Country: IE	Health Products Regulatory Authority	Identifier(s): 53010
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4400, 4401
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1091723
Country: MT	Medicines Authority	Identifier(s): MA639/02801, PI1438/05301A, PI908/16401B
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 322M2002
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 56774
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 9899
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100031517, 100129788, 100258209, 100264760, 100266083, 100267770, 100268159, 100305222, 100324662, 100336270, 100346310, 100349745, 100351370, 100405751, 100417435, 100426730, 100446603, 100458883, 100460054
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63899001, W63899002, W63899003, W63899004
Country: SG	Health Sciences Authority	Identifier(s): 12334P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699546093953, 8699546093960
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/18.8/0494